CareRx Corporation
CRRX.TOTSXHealthcare● Active
$3.24
+$0.03(+0.93%)
Market Cap$205568332
P/E Ratio—
52W High$4
52W Low$2.7
CareRx Corporation (CRRX.TO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CRRX.TO · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$0.02
Est. $0.04 · -50.0%
Revenue
$0.09B
Est. $0.10B · -2.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
CRRX.TO reports quarterly as a TSX-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | $0.02 | — | — | — | $0.09B | — |
| ▼ Q2 FY2026 | May 6, 2026 | $0.04 | $0.02 | -50.0% | $0.09B | $0.10B | -2.1% |
| ▲ Q1 FY2026 | Mar 4, 2026 | $0.03 | $0.37 | +1380.0% | $0.10B | $0.10B | +1.0% |
| ▼ Q4 FY2025 | Nov 3, 2025 | $0.03 | $0.02 | -9.8% | $0.09B | $0.10B | -2.1% |
| ▼ Q3 FY2025 | Jul 30, 2025 | $0.01 | $0.01 | -21.5% | $0.09B | $0.09B | -3.1% |
| ▼ Q2 FY2025 | May 7, 2025 | $0.01 | $0.00 | -65.2% | $0.09B | $0.09B | -2.8% |
| ▼ Q1 FY2025 | Mar 5, 2025 | $0.02 | -$0.03 | -250.0% | $0.09B | $0.09B | +1.2% |
| ▼ Q4 FY2024 | Nov 8, 2024 | -$0.00 | -$0.01 | -300.0% | $0.09B | $0.09B | +0.8% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
$0.02
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
$0.02
EPS Est.
$0.04
EPS Surpr.
-50.0%
Revenue
$0.09B
Q1 FY2026
Mar 4, 2026Beat
EPS Actual
$0.37
EPS Est.
$0.03
EPS Surpr.
+1380.0%
Revenue
$0.10B
Q4 FY2025
Nov 3, 2025Miss
EPS Actual
$0.02
EPS Est.
$0.03
EPS Surpr.
-9.8%
Revenue
$0.09B
Q3 FY2025
Jul 30, 2025Miss
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
-21.5%
Revenue
$0.09B
Q2 FY2025
May 7, 2025Miss
EPS Actual
$0.00
EPS Est.
$0.01
EPS Surpr.
-65.2%
Revenue
$0.09B
Q1 FY2025
Mar 5, 2025Miss
EPS Actual
-$0.03
EPS Est.
$0.02
EPS Surpr.
-250.0%
Revenue
$0.09B
Q4 FY2024
Nov 8, 2024Miss
EPS Actual
-$0.01
EPS Est.
-$0.00
EPS Surpr.
-300.0%
Revenue
$0.09B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2027 | $0.04 | $0.04 | $0.04 | 1 |
| Q2 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q1 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q4 FY2026 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2026 | $0.03 | $0.03 | $0.03 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -50.0% | $3.66 | $3.66 | +0.00% |
| ▲ Q1 FY2026 | Mar 4, 2026 | +1380.0% | $3.83 | $3.82 | -0.26% |
| ▼ Q4 FY2025 | Nov 3, 2025 | -9.8% | $3.59 | $3.50 | -2.51% |
| ▼ Q3 FY2025 | Jul 30, 2025 | -21.5% | $2.85 | $2.84 | -0.35% |
| ▼ Q2 FY2025 | May 7, 2025 | -65.2% | $2.63 | $2.58 | -1.90% |
| ▼ Q1 FY2025 | Mar 5, 2025 | -250.0% | $2.66 | $2.53 | -4.89% |
| ▼ Q4 FY2024 | Nov 8, 2024 | -300.0% | $1.82 | $1.90 | +4.40% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -2839.7% | $2.22 | $2.25 | +1.35% |
Q2 FY2026+0.00%
Report Date
May 6, 2026
EPS Beat/Miss
-50.0%
Price Before
$3.66
Price After
$3.66
Q1 FY2026-0.26%
Report Date
Mar 4, 2026
EPS Beat/Miss
+1380.0%
Price Before
$3.83
Price After
$3.82
Q4 FY2025-2.51%
Report Date
Nov 3, 2025
EPS Beat/Miss
-9.8%
Price Before
$3.59
Price After
$3.50
Q3 FY2025-0.35%
Report Date
Jul 30, 2025
EPS Beat/Miss
-21.5%
Price Before
$2.85
Price After
$2.84
Q2 FY2025-1.90%
Report Date
May 7, 2025
EPS Beat/Miss
-65.2%
Price Before
$2.63
Price After
$2.58
Q1 FY2025-4.89%
Report Date
Mar 5, 2025
EPS Beat/Miss
-250.0%
Price Before
$2.66
Price After
$2.53
Q4 FY2024+4.40%
Report Date
Nov 8, 2024
EPS Beat/Miss
-300.0%
Price Before
$1.82
Price After
$1.90
Q3 FY2024+1.35%
Report Date
Aug 8, 2024
EPS Beat/Miss
-2839.7%
Price Before
$2.22
Price After
$2.25
Avg Beat Reaction-0.26%
Avg Miss Reaction-0.56%
Beat Rate1 / 8 quarters
Largest Move-4.89% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CRRX.TO ends December
CareRx Corporation (CRRX.TO) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.02 — missing the analyst consensus of $0.04 by -50.0%. The next CRRX.TO earnings date is expected around September 1, 2026.
Each quarter, investors track CRRX.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CRRX.TO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CRRX.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CRRX.TO earnings · 5 questionsCareRx Corporation's next earnings report is expected around September 1, 2026. CRRX.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CRRX.TO historically reports after market close (AMC).
CRRX.TO earnings datewhen is CRRX.TO earningsCRRX.TO next earnings datewhen does CRRX.TO report earningsCRRX.TO earnings calendar
▸ Source: FMP · CareRx Corporation SEC filings · US GAAP · CareRx Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026